Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.46%74.100.0%$2395.49m
NVAXNovavax, Inc. 1.67%170.2999.2%$1218.87m
SRNESorrento Therapeutics, Inc. 5.95%14.421.8%$598.67m
GILDGilead Sciences, Inc. 0.79%69.351.0%$559.14m
AMGNAmgen, Inc. -0.36%240.691.3%$476.61m
REGNRegeneron Pharmaceuticals, Inc. -0.16%620.212.5%$429.51m
BNTXBioNTech SE -0.10%77.000.0%$399.56m
VRTXVertex Pharmaceuticals, Inc. -0.13%272.991.9%$368.45m
BIIBBiogen, Inc. 10.10%305.711.6%$361.06m
ILMNIllumina, Inc. -10.94%355.663.5%$336.82m
VXRTVaxart, Inc. 1.05%9.190.0%$280.99m
EBSEmergent BioSolutions, Inc. 2.91%130.666.4%$180.62m
ALXNAlexion Pharmaceuticals, Inc. -0.60%103.282.0%$166.60m
SGENSeattle Genetics, Inc. -0.83%160.456.0%$163.01m
IBIOiBio, Inc. -6.65%3.790.2%$158.51m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.